Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene down 13% after it pulls Revlimid filing
Celgene down 13% after it pulls Revlimid filing
Celgene down 13% after it pulls Revlimid filing
Submitted by
admin
on June 21, 2012 - 8:48am
Source:
Marketwatch
News Tags:
Celgene
Revlimid
Multiple Myeloma
Europe
Headline:
Celgene down 13% after it pulls Revlimid filing
Do Not Allow Advertisers to Use My Personal information
